Form 4: SELLAS Life Sciences CFO John Burns Disposes of Shares to Cover Tax Obligations

SELLAS Life Sciences CFO John Burns disposed of 7,165 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Summary

• John Burns, the CFO of SELLAS Life Sciences Group, Inc., disposed of 7,165 shares of common stock on December 4, 2024.
• The shares were sold at a price of $1.13 per share.
• This transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Mr. Burns directly owns 104,762 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither positive nor negative for the company's outlook, but is a normal part of operations.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for companies to withhold shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Similar transactions are common across the biotechnology industry where stock-based compensation is a significant part of executive pay.
• Many companies, such as Amgen, Gilead Sciences, and Regeneron, have executives who regularly file Form 4s for similar transactions related to stock options and RSUs.
• The number of shares sold and the price are typical for these types of transactions and are not unusual compared to industry benchmarks.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

SELLAS Life Sciences, John Burns, CFO, Form 4, Share Disposal, Restricted Stock Units, Tax Withholding